41
Stevenage Bioscience Catalyst Martino Picado eahsn.org | @TheEAHSN

Stevenage Bioscience Catalyst event 12 December 2016

Embed Size (px)

Citation preview

Page 1: Stevenage Bioscience Catalyst event 12 December 2016

StevenageBioscience Catalyst

Martino Picado

eahsn.org | @TheEAHSN

Page 2: Stevenage Bioscience Catalyst event 12 December 2016

The Eastern Academic HealthScience Network

eahsn.org | @TheEAHSN

Karen Livingstone

Page 3: Stevenage Bioscience Catalyst event 12 December 2016

11.30

eahsn.org | @TheEAHSN

Welcome Martino Picado,Chief Executive, Stevenage Bioscience Catalyst

11.40 IntroductionsKaren Livingstone, Director of Partnerships & IndustryEngagement and National Director, SBRI Healthcare

11.50 Local Enterprise Partnerships Paul Witcombe, Hertfordshire LEP

12.10 Sustainability and Transformation Plans (STPs)Victoria Corbishley, Core Programme Lead, Eastern AHSNCarol Roberts, Chief Executive of PresQIPPRobert Berry, Innovation lead, Kent Surrey and Sussex

13.15 What do you want from EAHSN - Ian Sandison to facilitate

13.4014.00

Lunch and networkingCLOSE of session

Agenda

Page 4: Stevenage Bioscience Catalyst event 12 December 2016

Hertfordshire Local EnterprisePartnerships

eahsn.org | @TheEAHSN

Paul Whitcombe

Page 5: Stevenage Bioscience Catalyst event 12 December 2016

Accelerating business-led growth

Page 6: Stevenage Bioscience Catalyst event 12 December 2016

We are a credible force for growth in the county

We have secured nearly £300 million of Government and EU funding to dateto invest in our people, places and businesses.

A1(M)Growth Area

M1/M25Growth Area

A10/M11Growth Area

A1M

M11

M1

M25

A10

Page 7: Stevenage Bioscience Catalyst event 12 December 2016

We are making it easier to work by improving transport links and broadband connections

We have invested in a package of road and rail improvements including the Metropolitan Line Extension and a new train station forHatfield.

Page 8: Stevenage Bioscience Catalyst event 12 December 2016

We are creating healthy, prosperous town centres

We have put in place ambitious regeneration plans for Hemel,Watford and Stevenage with further opportunities progressing in Hatfield.

Page 9: Stevenage Bioscience Catalyst event 12 December 2016

We are building lasting connections between schools and businesses

We are shaping the future workforce to meet local employers’ needs viaTheCareersand Enterprise Company, Skillmakersand Apprenticeships Ambassador Network.

Page 10: Stevenage Bioscience Catalyst event 12 December 2016

We are accelerating R&D for commercial success

We are investing in science-led incubation centres at Rothamsted Research, the University of Hertfordshire and Stevenage Bioscience Catalyst.

Page 11: Stevenage Bioscience Catalyst event 12 December 2016

We are unlocking new growth and job creation

We are providing free support to established businesses withhigh-growth potential via our Growth Hub. Weare investing instart-up support such as the new Ambition Broxbourne Business Centre.

Page 12: Stevenage Bioscience Catalyst event 12 December 2016

We are encouraging new inward investment

Our newly established Enterprise Zone aims to create an international y recognised employment zonefocusing on the emerging enviro-tech sector.

We are growing the visitor economy with our tourism service Visit Herts.

Page 13: Stevenage Bioscience Catalyst event 12 December 2016

We are supporting our key sectors

Creative industries:£1m Growing PlacesFund to support Elstree Studios expansion, helping to secure Netflix£100m production ofThe Crown, employing up to400 additionalpeople on site and injecting up to £30,000 per day into local economy.

Page 14: Stevenage Bioscience Catalyst event 12 December 2016

We are now delivering on our £221.5m Growth Deal…

Life sciences: £2.5m to support unique, innovative knowledge transfer partnership at theUniversity of Hertfordshire’s new Scientific Knowledge and Innovation Hub

Agri-tech: Daniel Hall Innovation Centre now open at Rothamsted, providing specialist incubationspace with six agri-tech businessesalready on site

Page 15: Stevenage Bioscience Catalyst event 12 December 2016

…and secured £55.3m EU funding for business support and skills projects

European Regional Development Fund: High-growth and start-ups businesses can access a new ERDF-funded business support services package from 2017

European Social Fund: Around£17m ESF allocated to promotesocial inclusion, employabilityand lifelong learning

Page 16: Stevenage Bioscience Catalyst event 12 December 2016

Hertfordshire’s economy

In summary, we are performing well in relation to other LEP areas but there are still major challenges around productivity and meeting the demand for skills in a tightening labour market. Our revised Strategic Economic Plan wil help to address some of these challenges and meet the growing needs ofbusinesses.

Page 17: Stevenage Bioscience Catalyst event 12 December 2016

We are ambitious for the future

wide

Partner: We wil continue to work with a range ofpartners.

Investor: We wil build on our significant

track record forinvestment.

Strategic Leader: We wil set out clear

priorities for economic growth.

Advocate: We wil ensure the voice of

business remains at the heart of our work.

Page 18: Stevenage Bioscience Catalyst event 12 December 2016

The Eastern Academic HealthScience Network

eahsn.org | @TheEAHSN

Karen Livingstone

Page 19: Stevenage Bioscience Catalyst event 12 December 2016

Academic Health Science Networks

15 Academic Health Science Networks across England

• Licensed and mainly funded by NHS England

• Promoting innovation in healthcare• Disseminating innovation – from the UK and

beyond• Improving care across whole systems• Providing access to the NHS for industry• Creating wealth and health• Collaboration – A B C

Business

ClinicianNHS service

Academia

eahsn.org | @TheEAHSN

Page 20: Stevenage Bioscience Catalyst event 12 December 2016

• 4.8 million people• > 650 companies• 43 NHS organisations• 7 Universities• Cambridge Biomedical

Campus/Science Parks

• Norwich Research Park

• Stevenage Biocatalyst• Global pharmaceutical

Presence• Health Enterprise East• Leading SBRI for NHS

Cambridge

Norwich

Stevenage

Colchester

lpswichBedford

Eastern Academic Health Science Network

eahsn.org | @TheEAHSN

Page 21: Stevenage Bioscience Catalyst event 12 December 2016

Refreshed Clinical Trials tool – re- launched with CRN

Refreshed Procurement tool –relaunched with Regional Hub

Horizon scanning, learning events & surgeries

Building on existing work Building on existing work

MedTechAccelerator STPs Test Beds

Needsarticulation/Identification

Innovation Exchange & user testing

groups

The Innovation Pathway – Economic Growth workA programme of business support has been developed for SMEs and industry partners in conjunction with key regional partners

MedTechAccelerator

Needs articulation/Identification

327 Businesses supported 78 hrs of business support

MedTechAccelerator STPs Test Beds

Needs

eahsn.org | @TheEAHSN

articulation/Identification

Page 22: Stevenage Bioscience Catalyst event 12 December 2016

eahsn.org | @TheEAHSN www.sbrihealthcare.co.uk

Page 23: Stevenage Bioscience Catalyst event 12 December 2016

SustainabilityTransformation

Plans

eahsn.org | @TheEAHSN

Victoria Corbishley

Page 24: Stevenage Bioscience Catalyst event 12 December 2016

Sustainability and Transformation Plans (STP)

eahsn.org | @TheEAHSN

• Outline of what the STP plans are, how they have been formulated and what they mean for NHS planning

• How the STPs in the East are taking forward their work – what projects you might be able to link into

• Key opportunities for new technologies and innovations

Page 25: Stevenage Bioscience Catalyst event 12 December 2016

What are the STP plans?

• 44 plans being developed by regions known as ‘footprints’

• These plans will be place based, multi-year plans built around the needs of local populations.

• They are umbrella plans that cover a range of delivery plans,different geographies and types of services

• The plans must show how they will achieve sustainable financial balance by March 2021

• The plans are expected to set out how the local area will implement a number of national priorities, such as seven day services, improving cancer outcomes and a paperless NHS

SOURCE: HEALTH SERVICE JOURNAL

eahsn.org | @TheEAHSN

Page 26: Stevenage Bioscience Catalyst event 12 December 2016

The three gaps STPs are trying to solve

eahsn.org | @TheEAHSN

The health and well being gap– Prevention– Health inequalities

The care and quality gap– Reshaping care delivery to address variations in outcomes– Harnessing technology

The funding and efficiency gap– £22bn of savings required nationally by 2020/21

Page 27: Stevenage Bioscience Catalyst event 12 December 2016

How they have been formulated

eahsn.org | @TheEAHSN

• April 2016: Footprints submitted their initial STPs

• May 2016: Conversations took place between footprints leads and leaders from the health ALBs (arms lengths bodies)

• 30 June 2016: Second deadline for submission

• July 2016: Regional conversations between footprint leads and leaders from the ALBs

• 21 October 2016: Final deadline for submission

• October - December 2016: Plans expected to be published

• Early 2017: Consultation on plans expected to take place.

Page 28: Stevenage Bioscience Catalyst event 12 December 2016

Why haven’t Hertfordshire and West Essex published?

eahsn.org | @TheEAHSN

Page 29: Stevenage Bioscience Catalyst event 12 December 2016

Regional finance and efficiency gap

eahsn.org | @TheEAHSN

The Hertfordshire plan is not yet published though some “leaks” have appeared.

We have used leaked numbers in the table opposite but these should be treated with caution until the plan is published

The financial bridges published

The deficit left is the social deficit which has been included in all the positions. The NHS only position is a 0.9m surplus

Regional total 1,617.30 2,021.70 - 47.60 293.10

£mThe do nothing

financial gap Savings2020/21 publishedidentified position

Cambridgeshire and Peterborough 547.00 548.50 1.50Suffolk and North East Essex 248.00 248.80 0.80Mid and South Essex 406.70 406.60 - 0.10

Norfolk and Waveney STP 415.60 365.80 - 49.80Hertfordshire - 452.00

£s for each head of

population588.17260.23338.92

401.55

Page 30: Stevenage Bioscience Catalyst event 12 December 2016

Which results in varying degrees of activity impact

-7% -13%

-30%-30%

-40%

-20%

-10%

0%C&P SNEE MSE N&W

A&E attendance changes

0

-11% -9.70%

-34%-40%

-20%

-30%

-10%

0%C&P SNEE MSE N&W

NEL changes

-8%

eahsn.org | @TheEAHSN

-7%

-14%-16.20%

-20%

-15%

-10%

-5%

0%C&P SNEE MSE N&W

Outpatient changes

• C& P provided financial breakdown but not always a consistent activity picture so we havebeen unable to include them routinely in the charts

• Norfolk & Waveney quoted different figures at stages through the document. In the plan on a page, they quote 20% reduction in A&E and a 20% reduction in NEL. This differs form numbers quoted in the left shift chart on pg. 32. We have shown the figures from pg. 32 but are uncertain which ones represent the shared position of the STP. N.B. If we took the reduced figures, the STP would still be the most aggressive in terms of activity reduction.

• The A&E attendance reduction figure for N&W by 20/21 equates to 65,000 attendancesbeing moved into other settings or not requiring treatment

Page 31: Stevenage Bioscience Catalyst event 12 December 2016

Improvingprevention

How the regional STPs are taking forward their work

Increasing self-care

Developing enhanced primary care

Putting outpatient care “out”

of hospitalEffective hospitals

Integrating MH

Specialist services

New Models of

careSTP focus areas

eahsn.org | @TheEAHSN

Page 32: Stevenage Bioscience Catalyst event 12 December 2016

How the regional STPs are taking forward their work

Improving prevention

Increasing self-care

Developing enhanced

primary care

Putting outpatient

care “out” of hospital

Effective hospitals

Integrating MH

Specialist services

New Models of

careSTP focus areas

Improving prevention Lifestyle interventions Health checks Screening services

Increasing self-care Virtual monitoring and consultations Wearable sensorsPatient education Peer support

Enhanced primary care GP practices increasing list sizes Offering enhanced services e.g. Lucentis injections

Outpatient services Moving outpatients into community settingsVirtual OP

Effective hospitals Centralising services (back office and clinical)Reducing unit cost of care to maintain or improve quality

Integrating MH Mentally healthy communitiesSingle point of access

New models of care Developing accountable care organisations

eahsn.org | @TheEAHSN

Page 33: Stevenage Bioscience Catalyst event 12 December 2016

Implementation challenges

eahsn.org | @TheEAHSN

• Workforce – do we have the right people, in the right roles with the right resources? If not where are we going to get them from? Do they know and buy into the plans developed?

• Technology – how can we get better at adopting and using technology to meet these challenges?

• Funding – how can we fund any investment needed to deliver the transformation ambitions? Link to estates

• Engagement – the plans need to be further developed and implemented with stronger engagement with all stakeholders

Page 34: Stevenage Bioscience Catalyst event 12 December 2016

Engagement challenges – one example

eahsn.org | @TheEAHSN

• The BMA recently completed a survey of 615 London GPs and Consultants to ask them their thoughts on STPs• Some of the key findings included:

– 53 per cent have not heard of STPs– 85 per cent have not had any information about STPs from their Trust– 88 per cent felt they were unable to influence decisions made by their CCG– 93 per cent felt they have not had enough information about how health services are being devolved in

pilot areas– 73 per cent do not know if devolution is happening in their area

• Some of the key findings among the GPs surveyed in London were:– 66 per cent have not heard of STPs– 87 per cent were not formally consulted about the STP– 76 per cent felt they were unable to influence decisions made by their CCG– 61 per cent did not know how to challenge or change the leadership of their CCG

Page 35: Stevenage Bioscience Catalyst event 12 December 2016

Key opportunities for new technologies and innovations

• Anything that supports the priority areas identified and helps our workforce deliver high quality, effective and efficient care

• Consider the radical redesign principles developed by the IHI

eahsn.org | @TheEAHSN

Page 36: Stevenage Bioscience Catalyst event 12 December 2016

Thank you

eahsn.org | @TheEAHSN

[email protected]@Corbishley

Page 37: Stevenage Bioscience Catalyst event 12 December 2016

Questions & Answers

eahsn.org | @TheEAHSN

Victoria Corbishley – Eastern AHSN

Carol Roberts – PresQiPP

Rob Berry – Kent Surrey and Sussex

Karen Livingstone – Eastern AHSN

Page 38: Stevenage Bioscience Catalyst event 12 December 2016

What help do you need?Ian Sandison

eahsn.org | @TheEAHSN

Page 39: Stevenage Bioscience Catalyst event 12 December 2016

Refreshed Clinical Trials tool – re- launched with CRN

Refreshed Procurement tool –relaunched with Regional Hub

Horizon scanning, learning events & surgeries

Building on existing work Building on existing work

MedTechAccelerator STPs Test Beds

Needsarticulation/Identification

Innovation Exchange & user testing

groups

The Innovation Pathway – Economic Growth workA programme of business support has been developed for SMEs and industry partners in conjunction with key regional partners

MedTechAccelerator

Needs articulation/Identification

MedTechAccelerator STPs Test Beds

Needs

eahsn.org | @TheEAHSN

articulation/Identification

Page 40: Stevenage Bioscience Catalyst event 12 December 2016

• Health needs identified• Navigation / connections• Clinical trials / research evidence• Connecting to procurement• Demonstrators• Connection to other AHSNs• Other ideas?

eahsn.org | @TheEAHSN

• Would you pay for support?• What would you prioritise?• What would give you an outcome

you can’t get elsewhere?• What would it mean to your

business?• Support to create?• Support to scale?

Page 41: Stevenage Bioscience Catalyst event 12 December 2016

The Eastern Academic HealthScience Network

eahsn.org | @TheEAHSN

[email protected]